Pharmaceutical Stocks Leading Stocks Ranking Top 10 (List Table)
Pharmaceutical Stocks Leading Stocks Ranking Top 10, to know the ranking of major leading stocks of traditional Chinese medicine. Ealing Pharmaceuticals, Buchanan Pharmaceuticals and other high-quality enterprises, showing the strong potential of traditional Chinese medicine, the following editorial brings the top ten ranking of leading stocks of pharmaceutical stocks, for all of you a great benefit, take a look together.
Pharmaceutical Stocks Leading Stocks Ranking Top Ten
1. Total Pharmaceuticals Leading: 600276 Hengrui Medicine
2. Total Chinese Medicine Leading: 000538 Yunnan Baiyao
3. Experimental New Drugs Leading: 603259 WuXi Kangde
4. Diabetes Leading: 600867 Tonghua Dongbao
5. I.V. infusion leader: 002422 Kelun Pharmaceuticals
6. Vitamin drugs leader: 002001 Xinhecheng
7. Blood products leader: 002007 Hualan Bio
8. Growth hormone leader: 000661 Changchun High-Tech
9. Central nervous system leader: 002262 Enhua Pharmaceutical
10. Ophthalmology service leader: 300015 Aier Ophthalmology
11. Dental service leader: 600763 Tongze Medical
12. Paste medicine leader: 002287 Qizheng Tibetan medicine
13. Nuclear medicine leader: 002675 Dongcheng Pharmaceutical
14. Pharmaceutical business Pharmaceutical business leader: 601607 Shanghai Pharmaceuticals
15. Household medical equipment leader: 002223 Yuyue Medical
16. Orthopedic materials leader: 002901 Dabo Medical
17. Heart stent leader: 300003 Lepu Medical
18. Pharmaceutical glass leader: 600529 Shandong Pharmaceutical Glass
19. 19. Vaccine leader: 300601 Kangtai Biological
20. Clinical CRO leader: 300347 Tiger Pharmaceuticals,
21. Independent laboratory leader: 603882 Golden Area Medical
22. Physical examination business leader: 002044 Meinian Health
23. Chemiluminescent diagnostic reagent leader: 603658 Antu Bio
24. blood perfusion equipment leader: 300529 Jianfan biology
25. pharmacy leader: 603939 Yifeng pharmacy
26. anti-allergy biological drug leader: 300357 I Wu biology
Chinese medicine related leading stocks what are
1. Yunnan Baiyao (000538):
Yunnan Baiyao was created in 1902 by Qu Huanzhang, originally known as "Qu Huanzhang Baibao Dan". Qu Huanzhang was originally in Yunnan Jiangchuan area is a famous injury doctor, after the disaster to avoid chaos, traveled to the south of Yunnan mountains, seek advice from the local ethnic doctors, study the local herbs, painstakingly study, improve the formula, after ten years, developed the "Hundred Treasures Dan", in addition, he also developed a tiger strength, support the bones of the scattered prescription. 1916, Qu Huanzhang will be together with the prescription of the white medicine to the Yunnan Yunnan Baiyao. In 1916, Qu Huanzhang gave them together with the prescription of Baiyao to the Health Institute of the Police Department of the Yunnan Provincial Government for inspection, and after passing the test, a certificate was issued to allow the public sale of the medicine. 1917, the Yunnan Baiyao was changed from a paper package to a ceramic bottle, and was marketed throughout the country, with a sharp increase in sales. 1923, the political situation in Yunnan was chaotic, and Qu Huanzhang, in the meantime, had to study and research the formula and summarize his clinical experience, so as to make the Yunnan Baiyao reach a better efficacy, and to form the "One Medicine, Three Dan" formula. "One Medicine into Three Dan and One Son", i.e. Ordinary Baibao Dan, Heavy Rising Baibao Dan, Three Rising Baibao Dan and Insurance Son. At this time, Baibaodan was well known overseas, and was very popular in Southeast Asia. 1931, Qu Huanzhang built the "Qu Huanzhang Pharmacy" on Jinbi Road in Kunming, and in 1955, Qu Huanzhang's wife, Miao Lanying, offered the formula for the drug to the government, and after that, Yunnan Baiyao began to be produced in other pharmaceutical factories.
2. Tongrentang (600085):
Beijing Tongrentang is a famous old Chinese medicine industry, founded in the Qing dynasty in Kangxi eight years (1669), since the first year of Yongzheng (1721) formally for the Qing dynasty Palace Royal Pharmacy medicine, through eight generations of emperors, up to 188 years. Successive generations of Tongrentang people have abided by the traditional motto of "not daring to save artificiality despite the complexity of concoctions, not daring to reduce material resources despite the cost of tastes", and set up the self-discipline of "no one can see the repair of harmony, and there is a heavenly knowledge of the existence of the heart", which has ensured the longevity of Tongrentang's golden brand name. Tongrentang's products are renowned at home and abroad for their unique formula, superior materials, exquisite craftsmanship and remarkable therapeutic effects, and are marketed in more than 40 countries and regions. At present, Tongrentang has formed the "1032" project of developing modern pharmaceutical industry, retail business and medical service under the overall framework of the Group, supporting the formation of ten major companies, two bases, two hospitals and two centers, of which there are two listed companies both inside and outside China, more than 800 retail outlets, 28 overseas joint ventures ("stores"), and more than 20 overseas joint ventures ("stores"). There are 28 overseas joint venture companies (stores) in 15 countries and regions.
3. Pientzehuang (600436):
Pientzehuang and Yunnan Baiyao are the same as two exclusive top-secret varieties of traditional Chinese medicine in China, whose special formula and unique technology are protected by the state top-secret. During the Wanli period of Ming Dynasty, there was a political change in the court, a doctor of imperial medicine was dissatisfied with the government and took the prescription out of the monks, and the archives were lost in the turmoil of Ming Dynasty, so the secret prescription of the doctor of imperial medicine of Ming Dynasty and Qing Dynasty was not found in the records, but it can be proved from the main party of Panax pseudoginseng in the prescription of Pientzehuang, which was firstly seen in the "Materia Medica Compendium" of Li Shizhen, and the time was 1556, and it was recorded that Panax pseudoginseng was produced in the southern mountains, which was both scarce and expensive, and it was used in the medicine of the palace, and then configured into a prescription and made into the secret formula of the palace with a special craft. Pientzehuang was designated as the secret formula of the court. When it is a treasure for heirloom, it takes quite a long time for it to be famous, the Tai doctor who cut his hair and became a monk was originally from Minnan, and after that, he presided over the rock temple in Pu Shan to teach his disciples for several generations. Some tea houses in Zhangzhou city began to make Pientzehuang in the Republican period. in 1956, the government announced the private transformation.
4. Dong'a Gum (000523):
Prices rise, sales volume may fall. Sales revenue rose 10.72% year-on-year, the main reason is also caused by rising prices, but compared to the price increases, significantly lower, so we have reason to believe that the company's gum products, although across the Spring Festival consumption peak, but the high price of gum products in the first quarter of the year-on-year decline in sales. We believe this is normal, after all, the market needs an adaptation process between the recognition of Colla Corii Asini products and price affordability. However, people's demand for healthcare and health products will still provide room for a sustained rise.
Multi-tier development strategy for Colla Corii Asini products. According to the characteristics of Colla Corii Asini, the company is directly located in the anti-fatigue, anti-hypoxia, blood nourishing and other aspects of health care products, accurate positioning, in the focus of the main business of Colla Corii Asini, shaping the "Dong'a Colla Corii Asini" high-end brand image at the same time, expanding the Colla Corii Asini category, initially formed the Colla Corii Asini as the center of the "drugs - health care products - food" gradually formed a "pharmaceutical - health care products - food". initially formed a strategic pattern centering on Colla Corii Asini and gradually extending to the field of large consumption with "drugs, health care products and food". We believe that the company's products are highly scalable, and we are particularly optimistic about the positioning and development of Colla Corii Asini's derivative products in various levels of the market.
Chinese medicine stocks leading stocks
What are the leading stocks of Chinese medicine:1 Pientzehuang;2 Yunnan Baiyao;3 Jiuzhitang;4 Tongrentang;5 Baiyunshan;6 JiangZhongPharmaceutical;7 Ma Yinglong. In addition, the Chinese medicine stocks are: Haiwang Biological, Fengyuan Pharmaceuticals, Dong'a Agaricus, Lizhu Group and so on. From the second half of last year, "the fifth batch of medicine collection" policy to carry out since the CSI pharmaceutical index has continued to retrace more than 20%, nearly a year dimension down -14%, while the CSI Chinese medicine index is "a standout", nearly a year up as much as nearly 40%, ranking first in the pharmaceutical sector. Ranked first in the pharmaceutical subsectors. 1, Tongrentang (600085): leading stocks of traditional Chinese medicine. October 22 news, Tongrentang as of 15:00, the stock rose 0.61%, at 33.11 yuan; 5 days within the share price fell 1.06%, the market value of 45.409 billion yuan.
The company has been listed for more than 10 years of growth and development, has formed to the core of the manufacturing of proprietary Chinese medicines, with the planting of Chinese herbal medicines, research and development of proprietary Chinese medicines, pharmaceutical logistics and distribution, pharmaceutical retailing of a more complete industrial chain.
2, Baiyunshan (600332): leading stocks of traditional Chinese medicine. October 22 news, Baiyunshan 5-day share price fell 0.5%, up 1.71% this year, the latest 29.8 yuan, the price-earnings ratio of 16.62.
Company is the domestic traditional Chinese medicine industry with the most varieties of the most complete, the largest number of Chinese old brand, the largest value of traditional Chinese medicine enterprises, traditional Chinese medicine varieties of more than 400 kinds, covering almost all of the traditional Chinese medicines. There are more than 400 kinds of traditional Chinese medicines, covering almost all traditional Chinese medicine classifications, 45 kinds of national Chinese medicine secondary protection varieties, of which more than 20 are exclusive production varieties, and there are more than 100 kinds of foreign brand-name pharmaceutical products exclusively represented by the company. Such as Wang Lao Ji, Chen Li Ji, Pan Gao Shou, Jing Xiu Tang, etc., all of which are long-established century-old stores. These include 20 exclusive products such as Quenching Thirst Pills and Hua Tuo Zaizao Pills. Wanglaoji Herbal Tea, Baoji Pills, Wu Ji Bai Feng Pills and other products are well-known in South China and Southeast Asia. After five enterprises of the company, including Wanglaoji Pharmaceuticals and Jingxiutang Pharmaceuticals, were selected as the first batch of "old Chinese brands", three enterprises, including Zhongyi Pharmaceuticals, were selected as the second batch of "old Chinese brands".
3, Pientzehuang (600436): leading stock of traditional Chinese medicine. on October 22, opening news, Pientzehuang latest reported 434.99 yuan, turnover 3.01 million lots, total market value is 262.437 billion yuan.
The company has been awarded the title of "high-tech enterprise" by the Ministry of Science and Technology of China, and passed the re-identification of high-tech enterprise, and has been evaluated as "Top 10 Chinese Traditional Medicine Enterprises with Scientific and Technological Innovation Output in 2015".
The other traditional Chinese medicine conceptual stocks are as follows: Tianyin Pharmaceuticals, JiuDian Pharmaceuticals, Erkang Pharmaceuticals, Qian Qian Pharmaceuticals. The company's main business is the development of a new product line, which will be launched in the next few years.
Top 10 TCM Leading Stocks
The top 10 TCM leading stocks are Pientzehuang, Yunnan Baiyao, Jiuzhitang, Essence Pharmaceuticals, Tongrentang, Baiyunshan, Kangyuan Pharmaceuticals, Jiangzhong Pharmaceuticals, Guangyuduan, and Ma Yinglong.
The market size of China's healthcare service industry reached 4.6 trillion yuan in 2019, with a 2015-2019 CAGR of 12%, and is expected to reach 10 trillion yuan in 2030.
Of these, China's traditional Chinese medicine (TCM) health industry has also expanded along with the development of the medical and health service industry.In 2019, the TCM health market size of RMB 917 billion yuan, and the in-depth analysis of the TCM industry and the "13th Five-Year Plan" development planning guidance research and analysis report predicts that the size of the TCM industry in 2030 is expected to reach RMB 224.2 billion, with an estimated 2019-2030 CAGR of 11.3%.
Top 10 Leading TCM Stocks
1, Hengrui Medicine - the absolute leader in innovative medicines
2, Fosun Pharmaceuticals - the leader in pharmaceutical distribution
3, Coren Pharmaceuticals - I.V. infusion leader
4, Health Yuan - biopharmaceutical leader
5, Renfo Pharmaceuticals - anesthesia market leader< /p>
6, Hesco - innovative drugs "small Hengrui"
7, Hualan Bio - a leading blood products
8, Anke Bio --Growth hormone drug leader
9, Myriad Medical - medical device leader
10, Kaili Medical - endoscopy leader